<DOC>
	<DOCNO>NCT01620372</DOCNO>
	<brief_summary>The FCCSS multicentric national large-scale collaborative population-based study child treat solid tumor 2000 France age 19 year . The study concern improve knowledge long-term effect cause cancer treatment include adverse health social outcome . The main reason FCCSS estimate risk adverse health social outcome may occur cancer treatment prevent provide adapt follow-up care . The cohort follow 20 year 2011 .</brief_summary>
	<brief_title>French Childhood Cancer Survivor Study</brief_title>
	<detailed_description>The main objective FCCSS : - estimate relationship dose receive ( radiotherapy , chemotherapy ) give organ risk second malignancy tumor ; - help identify patient high risk ; - compare mortality occur among survivor general population ; - investigate consequence various intensity exposure chemotherapy and/or radiation health outcome ( cardiovascular , cerebrovascular thyroid disease , diabetes , â€¦ ) ; - characterize survivor respect socioeconomic status quality life . The cohort ascertain use : - medical record treatment center order characterize childhood cancer , estimate dos radiotherapy receive organ measure chemotherapy administer ; - French National Identification Registry French Death Registry order obtain vital status cause death former patient - self-questionnaire cover entire future survivor ( e.g . social status , family network , fertile offspring , access care , access bank loan , occupation , ... ) ; - French National Health Insurance Information System contain data reimbursement health expenditure include medicinal product well outpatient medical nursing care , prescribe perform healthcare professional . In initial cohort , already study iatrogenic effect cancer treatment . We estimate dos ionise radiation deliver radiotherapy target volume organs distance . We find important role radiotherapy chemotherapy risk second cancer : - cancer occur childhood cancer excess compare general population , - study relationship brain radiation dose cerebrovascular mortality , - high risk cardiac pathology anthracyclines administration childhood cancer , - cancer treatment increase risk second malignant neoplasm digestive organ long latency period , - risk thyroid adenoma increase radiation dose receive thyroid childhood cancer treatment , plateaued high dos , - high long-term mortality risk type second malignant neoplasm whatever treatment receive .</detailed_description>
	<criteria>All type solid childhood cancer France Age diagnosis : Below age 19 Period diagnosis : 1st January 1942 31st December 1999 Complete identification ( first name , last name , date birth place birth ) Leukaemia case</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>